Regencell Bioscience Holdings Limited Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price
Regencell Bioscience Holdings Limited (RGC) had Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price of $10.45 per share as of 2021-08-19, per its 20-F filed 2024-10-25.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice · last filed 2024-10-25
- 2021-08-19: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $10.45.
- 2021-07-20: Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price $10.45.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price |
|---|---|
| 2021-08-19 | $10.45 20-F · filed 2024-10-25 |
| 2021-07-20 | $10.45 20-F · filed 2024-10-25 |